Mark A. Rubin

165.7k total citations · 18 hit papers
552 papers, 49.9k citations indexed

About

Mark A. Rubin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Mark A. Rubin has authored 552 papers receiving a total of 49.9k indexed citations (citations by other indexed papers that have themselves been cited), including 311 papers in Pulmonary and Respiratory Medicine, 242 papers in Molecular Biology and 123 papers in Cancer Research. Recurrent topics in Mark A. Rubin's work include Prostate Cancer Treatment and Research (259 papers), Prostate Cancer Diagnosis and Treatment (128 papers) and Cancer Genomics and Diagnostics (57 papers). Mark A. Rubin is often cited by papers focused on Prostate Cancer Treatment and Research (259 papers), Prostate Cancer Diagnosis and Treatment (128 papers) and Cancer Genomics and Diagnostics (57 papers). Mark A. Rubin collaborates with scholars based in United States, Switzerland and Germany. Mark A. Rubin's co-authors include Arul M. Chinnaiyan, Kenneth J. Pienta, Sooryanarayana Varambally, Rajal B. Shah, Scott A. Tomlins, Debashis Ghosh, Saravana M. Dhanasekaran, Francesca Demichelis, Sven Perner and Rohit Mehra and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Mark A. Rubin

541 papers receiving 48.9k citations

Hit Papers

Recurrent Fusion of TMPRSS2 and ETS Transcription Factor ... 2001 2026 2009 2017 2005 2002 2001 2003 2005 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
    2005 2.8k citations Scott A. Tomlins, Daniel R. Rhodes et al. Science profile →
  2. The polycomb group protein EZH2 is involved in progression of prostate cancer
    2002 2.1k citations Sooryanarayana Varambally, Saravana M. Dhanasekaran et al. profile →
  3. Delineation of prognostic biomarkers in prostate cancer
    2001 1.3k citations Saravana M. Dhanasekaran, Debashis Ghosh et al. profile →
  4. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
    2003 1.3k citations Sooryanarayana Varambally, Scott A. Tomlins et al. profile →
  5. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
    2005 1.1k citations Levi A. Garraway, Hans R. Widlund et al. profile →
  6. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
    2016 1.1k citations Himisha Beltran, Juan Miguel Mosquera et al. profile →
  7. Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
    2006 843 citations Todd R. Golub, Mark A. Rubin et al. Cancer Research profile →
  8. Integrative molecular concept modeling of prostate cancer progression
    2006 694 citations Scott A. Tomlins, Rohit Mehra et al. profile →
  9. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
    2005 612 citations Sooryanarayana Varambally, Daniel R. Rhodes et al. profile →
  10. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
    2007 610 citations Scott A. Tomlins, Saravana M. Dhanasekaran et al. profile →
  11. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.
    2002 516 citations Daniel R. Rhodes, Mark A. Rubin et al. profile →
  12. Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
    2008 513 citations Scott A. Tomlins, Sooryanarayana Varambally et al. profile →
  13. I NTERGROUP B IAS
    2002 504 citations Mark A. Rubin et al. profile →
  14. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
    2018 481 citations Andrea Sboner, Himisha Beltran et al. profile →
  15. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
    2022 399 citations Holger Moch, Mark A. Rubin et al. profile →
  16. Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
    2014 375 citations Himisha Beltran, Juan Miguel Mosquera et al. profile →
  17. Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
    2009 310 citations Rameen Beroukhim, Arianna Di Napoli et al. Cancer Research profile →
  18. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors
    2022 140 citations Mark A. Rubin, Holger Moch et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Rubin United States 113 26.8k 23.2k 13.3k 10.4k 4.0k 552 49.9k
Charles L. Sawyers United States 99 24.8k 0.9× 15.9k 0.7× 9.3k 0.7× 12.3k 1.2× 4.2k 1.0× 266 53.4k
Kenneth J. Pienta United States 116 21.8k 0.8× 17.5k 0.8× 12.1k 0.9× 18.0k 1.7× 3.4k 0.9× 675 49.8k
David N. Louis United States 99 27.9k 1.0× 17.5k 0.8× 17.0k 1.3× 15.3k 1.5× 3.0k 0.8× 322 75.2k
Daniel A. Haber United States 106 35.1k 1.3× 19.4k 0.8× 14.0k 1.1× 26.3k 2.5× 5.9k 1.5× 286 63.7k
Ming‐Sound Tsao Canada 98 16.5k 0.6× 13.8k 0.6× 8.3k 0.6× 15.3k 1.5× 1.7k 0.4× 653 37.2k
Andreas von Deimling Germany 105 22.7k 0.8× 10.4k 0.5× 13.1k 1.0× 9.1k 0.9× 2.1k 0.5× 652 59.5k
Matt van de Rijn United States 86 23.4k 0.9× 9.7k 0.4× 16.4k 1.2× 19.3k 1.9× 4.9k 1.2× 251 50.2k
Webster K. Cavenee United States 99 31.7k 1.2× 8.8k 0.4× 13.7k 1.0× 12.7k 1.2× 4.3k 1.1× 315 62.0k
Martin Gleave Canada 98 15.6k 0.6× 15.8k 0.7× 8.7k 0.7× 9.0k 0.9× 2.4k 0.6× 680 32.4k
Nikolaus Schultz United States 67 24.8k 0.9× 9.9k 0.4× 12.8k 1.0× 11.7k 1.1× 3.2k 0.8× 228 39.0k

Countries citing papers authored by Mark A. Rubin

Since Specialization
Citations

This map shows the geographic impact of Mark A. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Rubin more than expected).

Fields of papers citing papers by Mark A. Rubin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Rubin. The network helps show where Mark A. Rubin may publish in the future.

Co-authorship network of co-authors of Mark A. Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Rubin. A scholar is included among the top collaborators of Mark A. Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Rubin. Mark A. Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Linda, Helen Fernandes, Peyman Tavassoli, et al.. (2016). The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations. Journal of the American Medical Informatics Association. 24(3). 513–519. 67 indexed citations
2.
Khani, Francesca, Juan Miguel Mosquera, Kyung Park, et al.. (2014). Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men. Clinical Cancer Research. 20(18). 4925–4934. 116 indexed citations
3.
Lin, Pei‐Chun, Ya‐Lin Chiu, Samprit Banerjee, et al.. (2012). Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression. Cancer Research. 73(3). 1232–1244. 144 indexed citations
4.
Friedlander, Terence W., Ritu Roy, Scott A. Tomlins, et al.. (2011). Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer. Cancer Research. 72(3). 616–625. 88 indexed citations
5.
Jané‐Valbuena, Judit, Hans R. Widlund, Sven Perner, et al.. (2010). An Oncogenic Role for ETV1 in Melanoma. Cancer Research. 70(5). 2075–2084. 81 indexed citations
6.
Setlur, Sunita R., Chen X. Chen, Jung‐Sook Ha, et al.. (2010). Genetic Variation of Genes Involved in Dihydrotestosterone Metabolism and the Risk of Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 19(1). 229–239. 47 indexed citations
7.
Vizio, Dolores Di, Jayoung Kim, Martin H. Hager, et al.. (2009). Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease. Cancer Research. 69(13). 5601–5609. 334 indexed citations
8.
Hofer, Matthias D., Rainer Kuefer, Christiane Maier, et al.. (2009). Genome-Wide Linkage Analysis of TMPRSS2-ERG Fusion in Familial Prostate Cancer. Cancer Research. 69(2). 640–646. 25 indexed citations
9.
Steinkamp, Mara P., Michele Brogley, Haniya Rehman, et al.. (2009). Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy. Cancer Research. 69(10). 4434–4442. 159 indexed citations
10.
Rickman, David S., Dorothee Pflueger, B.J. Moss, et al.. (2009). SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation–Specific Fusion Transcript in Prostate Cancer. Cancer Research. 69(7). 2734–2738. 155 indexed citations
11.
Beroukhim, Rameen, Arianna Di Napoli, Kirsten D. Mertz, et al.. (2009). Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney. Cancer Research. 69(11). 4674–4681. 310 indexed citations breakdown →
12.
Kelly, Kimberly M., Sunita R. Setlur, Robert W. Ross, et al.. (2008). Detection of Early Prostate Cancer Using a Hepsin-Targeted Imaging Agent. Cancer Research. 68(7). 2286–2291. 88 indexed citations
13.
Banyard, Jacqueline, Lere Bao, Matthias D. Hofer, et al.. (2007). Collagen XXIII Expression Is Associated with Prostate Cancer Recurrence and Distant Metastases. Clinical Cancer Research. 13(9). 2634–2642. 41 indexed citations
14.
Setlur, Sunita R., Thomas Royce, Andrea Sboner, et al.. (2007). Integrative Microarray Analysis of Pathways Dysregulated in Metastatic Prostate Cancer. Cancer Research. 67(21). 10296–10303. 60 indexed citations
15.
Kim, Jung H., Saravana M. Dhanasekaran, Rohit Mehra, et al.. (2007). Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression. Cancer Research. 67(17). 8229–8239. 88 indexed citations
16.
Febbo, Phillip G., Aaron R. Thorner, Mark A. Rubin, et al.. (2006). Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer. Clinical Cancer Research. 12(1). 152–158. 20 indexed citations
17.
Perner, Sven, Francesca Demichelis, Rameen Beroukhim, et al.. (2006). TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer. Cancer Research. 66(17). 8337–8341. 388 indexed citations
18.
Tomlins, Scott A., Daniel R. Rhodes, Sven Perner, et al.. (2005). Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer. Science. 310(5748). 644–648. 2820 indexed citations breakdown →
19.
Zhao, Xiaojun, Barbara A. Weir, Thomas LaFramboise, et al.. (2005). Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis. Cancer Research. 65(13). 5561–5570. 242 indexed citations
20.
Santagata, Sandro, Francesca Demichelis, Alberto Riva, et al.. (2004). JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence. Cancer Research. 64(19). 6854–6857. 271 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles L. Sawyers Breakdown of academic impact, for papers by Kenneth J. Pienta Breakdown of academic impact, for papers by David N. Louis Breakdown of academic impact, for papers by Daniel A. Haber Breakdown of academic impact, for papers by Ming‐Sound Tsao Breakdown of academic impact, for papers by Andreas von Deimling Breakdown of academic impact, for papers by Matt van de Rijn Breakdown of academic impact, for papers by Webster K. Cavenee Breakdown of academic impact, for papers by Martin Gleave Breakdown of academic impact, for papers by Nikolaus Schultz
Rankless by CCL
2026